Background: Pediatric patients with steroid-resistant nephrotic syndrome (SRNS) and focal segmental glomerulosclerosis (FSGS) may relapse and current second line agents include mycophenolate mofetil. However, there is no current information about the use of the sodium salt of mycophenolic acid (SMPA) in this population.Objectives: We conducted a prospective study on the efficacy and pharmacokinetics of SMPA in children with FSGS.Patients and Methods: Patients without NPHS2 pathogenic variants received SMPA at dosages between 460 to 720 mg/m2/d for 12 months after previous treatments failure. Clinical and biochemical assessments were performed. Blood samples were obtained after the first dose and at steady state (3 months after the onset of ...
Mycophenolic acid (MPA) is an effective treatment for active lupus nephritis despite its variable ef...
Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid (MPA), is an effective immunosuppressive...
The delayed release of mycophenolic acid (MPA) from enteric-coated mycophenolate sodium (EC-MPS) may...
Background: Mycophenolate mofetil (MMF) has emerged as a new agent for treatment of a variety of gl...
PubMedID: 14964454Aim: The aim of the present study is to report our clinical experiences with MMF i...
International audienceBACKGROUND AND OBJECTIVES:Therapeutic drug monitoring of mycophenolic acid can...
ABSTRACT: BACKGROUND: : Therapy with mycophenolate mofetil (MMF) has become a valuable therapeutic o...
BACKGROUND: Several factors may decrease plasma protein binding of mycophenolic acid (MPA), the acti...
Background: Idiopathic nephrotic syndrome (INS) necessitates administration of corticosteroids or co...
The purpose of this study was to assess the results of therapy with mycophenolate mofetil (MMF) in c...
International audienceBackground: Mycophenolic acid (MPA), the active compound of mycophenolate mofe...
BACKGROUND: The use of mycophenolate mofetil (MMF) in autoimmune disease is often limited by adverse...
The delayed release of mycophenolic acid (MPA) from enteric-coated mycopbenolate sodium (EC-MPS) may...
textabstractWe performed a multi-centre randomized controlled trial to compare the efficacy of mycop...
Introduction: Mycophenolate mofetil (MMF) is an ester prodrug of the immunosuppressant mycophenolic ...
Mycophenolic acid (MPA) is an effective treatment for active lupus nephritis despite its variable ef...
Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid (MPA), is an effective immunosuppressive...
The delayed release of mycophenolic acid (MPA) from enteric-coated mycophenolate sodium (EC-MPS) may...
Background: Mycophenolate mofetil (MMF) has emerged as a new agent for treatment of a variety of gl...
PubMedID: 14964454Aim: The aim of the present study is to report our clinical experiences with MMF i...
International audienceBACKGROUND AND OBJECTIVES:Therapeutic drug monitoring of mycophenolic acid can...
ABSTRACT: BACKGROUND: : Therapy with mycophenolate mofetil (MMF) has become a valuable therapeutic o...
BACKGROUND: Several factors may decrease plasma protein binding of mycophenolic acid (MPA), the acti...
Background: Idiopathic nephrotic syndrome (INS) necessitates administration of corticosteroids or co...
The purpose of this study was to assess the results of therapy with mycophenolate mofetil (MMF) in c...
International audienceBackground: Mycophenolic acid (MPA), the active compound of mycophenolate mofe...
BACKGROUND: The use of mycophenolate mofetil (MMF) in autoimmune disease is often limited by adverse...
The delayed release of mycophenolic acid (MPA) from enteric-coated mycopbenolate sodium (EC-MPS) may...
textabstractWe performed a multi-centre randomized controlled trial to compare the efficacy of mycop...
Introduction: Mycophenolate mofetil (MMF) is an ester prodrug of the immunosuppressant mycophenolic ...
Mycophenolic acid (MPA) is an effective treatment for active lupus nephritis despite its variable ef...
Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid (MPA), is an effective immunosuppressive...
The delayed release of mycophenolic acid (MPA) from enteric-coated mycophenolate sodium (EC-MPS) may...